53.41 -0.24 (-0.45%)
Pre-Market: 8:35AM EDT
|Bid||53.38 x 1200|
|Ask||53.70 x 3100|
|Day's Range||53.08 - 53.70|
|52 Week Range||46.48 - 64.94|
|Beta (5Y Monthly)||0.21|
|PE Ratio (TTM)||35.40|
|Forward Dividend & Yield||1.40 (2.61%)|
|Ex-Dividend Date||Feb. 25, 2021|
|1y Target Est||63.60|
Dr. Dori Russ, Medical Director of the Russ Group, joined Yahoo Finance to discuss the latest on covid-19.
Dr. Richard Besser, Former Acting CDC Director, Robert Wood Johnson Foundation President & CEO, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus pandemic.
AstraZeneca (NASDAQ: AZN) at one time seemed to be in the driver's seat in the COVID-19 vaccine race. However, the big drugmaker has faced quite a few challenges in recent months, including a lawsuit filed by the European Union.